NPPA and central nervous system cancer: However, the surviving fraction was reduced another 80% relative to BCNU alone when cells were co-treated with BCNU and 20 μM 680C91 (Figure 3E), indicative of synergy between BCNU-induced DNA damage and KP blockade in the impairment of glioma cell proliferation.